Brain Association Iasi
Threat Assessment Brief: Implications for the EU/EEA on the spread of the SARS-CoV-2 Delta ( B.1.617.2 ) variant of concern
The aim of this threat assessment brief is to assess potential public health implications of the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) for the European Union and European Economic Area (EU/EEA).
Categories: C.D.C. (Europe)
Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update
This report assesses SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA.
Categories: C.D.C. (Europe)
Threat Assessment Brief: Emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA
The aim of this Threat Assessment Brief is to assess potential public health implications of B.1.617 variants for EU/EEA countries, with a focus on lineage B.1.617.2.
Categories: C.D.C. (Europe)
Threat Assessment Brief: Dengue epidemic in Réunion, 2021
This document assesses the risk related to dengue for EU/EEA citizens travelling to or residing in Réunion, and the risk related to having an outbreak of dengue in mainland EU/EEA following introduction of the virus from Réunion.
Categories: C.D.C. (Europe)
Risk Assessment: Emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries
This document assesses the risk associated with the dissemination of carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp) of sequence type (ST) 23 and other STs in the European Union/European Economic Area (EU/EEA).
Categories: C.D.C. (Europe)
